Yesterday, the Rovira i Virgili University (URV) awarded the scientist María Vallet Regí Doctor Honoris Causa. Vallet is a pioneering scientist in the field of applied chemistry in medicine. And it is doubly so: initially for its contribution to achieving bone tissue regeneration with the use of inorganic mesoporous ceramic materials, and since 2001 with the opening of a new field of research based on the use of these same materials for the transport and release of drugs in the treatment of infections, cancers, bone diseases and osteoporosis. Applications to patients in this second field will still have to wait a few years, but the qualitative leap will be relevant.
Yolanda Cesteros, Dean of the URV’s Faculty of Chemistry, sponsored Vallet, Professor of Inorganic Chemistry at the Complutense University of Madrid’s Faculty of Pharmacy, to form part of the URV faculty on the occasion of the 50th anniversary of studies in Chemistry in Tarragona. Cesteros expressed in the laudatio (explanatory statement) the importance of Vallet’s leadership in paving the way and integrating different disciplines, such as chemistry, biology, pharmacology, engineering, medicine and physics, to achieve solutions for human health.
Vallet stated that she was happy to contribute to improving people’s health and recalled “the social value” and also “the economic value” of scientific advances in this field due to the high added value conferred by innovation and knowledge.
The rector, María José Figueras, highlighted the relevance of the figure of María Vallet, the resilience that has allowed her to develop as a scientist and pioneer in biomedicine, and the firm defense of science to promote social progress and peace in the world. (He participated in the Governing Committee of the NATO Science for Peace Program between 1999 and 2005). Figueras pointed out that Vallet has joined the list of honorary women from the URV. In fact, she is the 48th honorary doctor in a group that includes 39 men and 9 women.